glp 1 eye issues Semaglutide Tied to Increased Risk of Serious Disease The Link between GLP-1 Drugs
Description
Curious about Microdosing GLP-1
Interesting to see Menu-Order-AI highlighted as part of a new category: medication-aware dining
By Tim Carl
Much anticipated Phase II results in obesity for Amgens GLP-1 agonist/GIP antagonist showed up to 20% weight loss, but without detailed data the drugs competitiveness is hard to ascertain.
